Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» Seattle Genetics
Seattle Genetics
Seattle Children's teams up with Juno competitor on gene editing research
Seattle Children's teams up with Juno competitor on gene editing research
Bizjournals.com
Seattle Genetics
Juno Therapeutics
Bluebird Bio
gene editing
Flag link:
Seattle Genetics sets out to raise $400M through common stock offering
Seattle Genetics sets out to raise $400M through common stock offering
Bizjournals.com
Seattle Genetics
stock offering
Flag link:
Seattle Genetics drug wins FDA approval, could boost biotech's revenue
Seattle Genetics drug wins FDA approval, could boost biotech's revenue
Bizjournals.com
FDA
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Flag link:
Seattle Genetics reports 2nd-quarter loss, misses expectations
Seattle Genetics reports 2nd-quarter loss, misses expectations
Yahoo/AP
Seattle Genetics
earnings
Flag link:
Growing Seattle Genetics tests cancer therapy for treatment of lupus
Growing Seattle Genetics tests cancer therapy for treatment of lupus
Bizjournals.com
Seattle Genetics
lupus
Adcetris
Flag link:
Seattle Genetics conjugates with immuno-oncology upstart Unum in $645M deal
Seattle Genetics conjugates with immuno-oncology upstart Unum in $645M deal
Fierce Biotech
Seattle Genetics
immuno-oncology
Unum Therapeutics
Flag link:
Top-Performing Biotech and Drug Stocks During ASCO '15
Top-Performing Biotech and Drug Stocks During ASCO '15
TheStreet.com
ASCO
Ignyta
Immunogen
Puma Biotechnology
AbbVie
Roche
Bristol-Myers Squibb
Seattle Genetics
Juno Therapeutics
Flag link:
Workers wanted: Seattle Genetics experiencing a growth spurt
Workers wanted: Seattle Genetics experiencing a growth spurt
BioPharma Dive
Seattle Genetics
hirings
Flag link:
Seattle Genetics on a 'great trajectory,' looks to grow staff by 100
Seattle Genetics on a 'great trajectory,' looks to grow staff by 100
Bizjournals.com
Seattle Genetics
hirings
Flag link:
4 Big Biopharma Deals We Might See In 2015
4 Big Biopharma Deals We Might See In 2015
Seeking Alpha
AbbVie
AstraZeneca
Biomarin
Bristol-Myers Squibb
Celgene
Gilead Sciences
GSK
Hospira
Jazz Pharmaceuticals
Merck
Seattle Genetics
Shire
Flag link:
4 big biopharma deals we might see in 2015
4 big biopharma deals we might see in 2015
BioPharma Dive
M&A
Merck
Jazz Pharmaceuticals
Shire
Biomarin
Gilead Sciences
Seattle Genetics
Pfizer
Celgene
Flag link:
Seattle Genetics reports fourth-quarter loss but tops expectations
Seattle Genetics reports fourth-quarter loss but tops expectations
Yahoo/AP
Seattle Genetics
earnings
Flag link:
Seattle Genetics: Good Tech, But On The Wrong Path
Seattle Genetics: Good Tech, But On The Wrong Path
Seeking Alpha
Seattle Genetics
antibody-drug conjugate
Flag link:
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
TheStreet.com
Agios Pharmaceuticals
Novartis
CAR-T
Celgene
Amgen
Merck
Bristol-Myers Squibb
Seattle Genetics
Sunesis
Flag link:
Seattle Genetics Makes Case for Expanded Use of Adcetris as Lymphoma Maintenance Therapy
Seattle Genetics Makes Case for Expanded Use of Adcetris as Lymphoma Maintenance Therapy
The Street
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Flag link:
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting
Yahoo/BusinessWire
Seattle Genetics
SGN-CD19A
acute lymphoblastic leukemia
leukemia
non-Hodgkin's lymphoma
diffuse large B-cell lymphoma
Flag link:
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting
Yahoo/BusinessWire
Seattle Genetics
Takeda
Adcetris
Hodgkin's lymphoma
Flag link:
Today's Water-Logged And Getting Wetter Stock: Seattle Genetics (SGEN)
Today's Water-Logged And Getting Wetter Stock: Seattle Genetics (SGEN)
TheStreet.com
Seattle Genetics
Flag link:
Aegerion, Seattle Genetics CEOs Accused in Suit of Cocaine Use
Aegerion, Seattle Genetics CEOs Accused in Suit of Cocaine Use
TheStreet.com
Aegerion
Seattle Genetics
Pharma CEOs
Flag link:
Seattle Genetics Seeks Expanded Use of Lymphoma Drug Following Study Win
Seattle Genetics Seeks Expanded Use of Lymphoma Drug Following Study Win
TheStreet.com
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Flag link:
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »